Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

How EMA and FDA Are Preparing for the Next COVID-19 Wave ?

EMA and FDA have revised their COVID-19 vaccine strategies in 2025, focusing on LP.8.1 and evidence-based approvals. This blog explores regulatory changes, manufacturer impacts, and what to expect moving forward.
  • Uncategorized
Mature Lady Preparing To Get Vaccinated Against Covid-19 In Clinic

How Remote Patient Monitoring Enhances Patient Care ?

Remote Patient Monitoring is not just a technology—it’s a paradigm shift in healthcare delivery. It empowers patients with more control over their health while providing healthcare providers with the data they need for timely interventions. As adoption grows, RPM promises
  • Medical Devices

Pharmaceutical Marketing: Essential Insights for Success

Marketing in Pharma and Medtech is challenging—but rewarding. With the right training from Pharmuni, professionals can become trusted voices in healthcare, shaping responsible messages that support both commercial success and patient well-being.
  • Quality Management System
Nitrosamines Compliance with Requirements

Major Regulatory Guidelines on Isolators & RABS

Isolators and RABS both play critical roles in modern aseptic manufacturing, but their regulatory expectations differ significantly. FDA, EU, and ISO guidelines emphasize risk-based design, validated control measures, and procedural discipline.
  • Aseptic Manufacturing, GMP, Uncategorized
The isolator effectively separates the production area from personnel and the surrounding environment from contamination

Understanding Isolators in the Pharmaceutical Industry – A Simple Guide

Pharmaceutical isolators have revolutionized aseptic manufacturing by offering a controlled, contamination-free environment that enhances both product safety and operator protection.
  • Blog, GMP, GxP

The Role of Isolators and RABS in Aseptic Manufacturing

As the pharmaceutical industry continues to evolve, aseptic processing must keep pace with advancing technologies. The choice between Open RABS, Closed RABS, and Isolators is crucial in ensuring sterility, regulatory compliance, and cost-effectiveness in injectable manufacturing.
  • Aseptic Manufacturing, Blog, GMP

Impact of EU GMP Annex 1 Revision on Sterile Manufacturing

Annex 1 is part of the European Good Manufacturing Practice (EU GMP) guidelines, specifically addressing the production of sterile pharmaceutical products. Companies manufacturing injectables, ophthalmic solutions, sterile powders, and other sterile dosage forms must comply with these regulations to meet
  • GMP, GxP
A focused technician operating machinery in a cleanroom environment.

Recent Updates in the Regulation of Nitrosamine Impurities

The regulation of nitrosamine impurities has been evolving rapidly due to concerns about their potential health risks, particularly their carcinogenicity. Regulatory authorities worldwide, including the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the Therapeutic Goods
  • Nitrosamine
Pharmacy shopping and drug abuse

How to predict for the formation of NDSRIs ?

The detection of N-nitrosamine impurities in medicines and the increasing presence of nitrosamine drug substance-related impurities (NDSRIs) have presented significant challenges for both drug manufacturers and regulatory agencies.
  • Blog, Nitrosamine
Female pharmacist staring at packaged pharmaceutical drugs in her hands

Guide to FDA Drug Product Recalls Avoidance

FDA drug recalls play a critical role in protecting public health by ensuring that unsafe or defective products are removed from the market. Staying ahead of compliance challengesFDA recalls are costly, but proactive compliance measures can significantly reduce the risks.
  • Audit and Inspection, Blog, GxP
Pharmacy, shopping and man reading medicine box, customer supplements product or drugs store pharma